The plasticity and potential of leukemia cell lines to differentiate into dendritic cells (Review)

Guo,Qingwei; Zhang,Leling; Li,Fu; Jiang,Guosheng

doi:10.3892/ol.2012.821

The plasticity and potential of leukemia cell lines to differentiate into dendritic cells (Review)

Authors:
- Qingwei Guo
- Leling Zhang
- Fu Li
- Guosheng Jiang
View Affiliations

Affiliations: Qilu Children's Hospital of Shandong University, Jinan 250022, P.R. China, Institute of Basic Medicine, Shandong Academy of Medical Science, Shandong Key Laboratory for Rare and Uncommon Diseases, Jinan 250062, P.R. China
Published online on: July 25, 2012 https://doi.org/10.3892/ol.2012.821
Pages: 595-600

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Dendritic cells (DCs) are potent antigen-presenting cells that orchestrate the innate and adaptive immune systems to induce immunity. DCs are significant in maintaining immune tolerance towards self-antigens, organ transplantation and allergic responses. DCs are powerful adjuvants for eliciting T-cell immunity and are therefore considered primary targets for inducing immune responses in the prevention and treatment of infectious diseases and cancer. DCs have been increasingly applied in the immunotherapy of cancer worldwide during the last decade; however, a number of the highly specialized biological characteristics of DCs remain to be elucidated. Previous studies of human DCs have been constrained by certain difﬁculties, therefore the majority of studies have been carried out using in vitro model systems. Suitable cell lines with dendritic‑like properties may provide valuable tools for the study of DC physiology and pathology. In the current review, various human DC line differentiation models are discussed. Certain cell lines provide valuable tools for studying the specific aspects of DC biology, despite variations in cell biological and immunological features when compared with primary DCs.

View Figures

View References

1.	J BanchereauRM SteinmanDendritic cells and the control of immunityNature392245252199810.1038/32588
2.	J BanchereauF BriereC CauxImmunobiology of dendritic cellsAnnu Rev Immunol18767811200010.1146/annurev.immunol.18.1.767
3.	R SpörriC Reise e SousaInflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper functionNat Immunol6163170200515654341
4.	D HawigerK InabaY DorsettDendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivoJ Exp Med194769779200110.1084/jem.194.6.76911560993
5.	RM SteinmanZA CohnIdentification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distributionJ Exp Med13711421162197310.1084/jem.137.5.1142
6.	WC Van VoorhisLS HairRM SteinmanG KaplanHuman dendritic cells. Enrichment and characterization from peripheral bloodJ Exp Med1551172118719826460832
7.	MK CrowHG KunkelHuman dendritic cells: major stimulators of the autologous and allogeneic mixed leucocyte reactionsClin Exp Immunol493383461982
8.	K InabaM InabaN RomaniGeneration of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factorJ Exp Med17616931702199210.1084/jem.176.6.16931460426
9.	N RomaniS GrunerD BrangProliferating dendritic cell progenitors in human bloodJ Exp Med1808393199410.1084/jem.180.1.838006603
10.	SM KiertscherMD RothHuman CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4J Leukoc Biol592082181996
11.	SJ CollinsFW RuscettiRE GallagherRC GalloNormal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxideJ Exp Med149969974197910.1084/jem.149.4.969
12.	TR BreitmanSE SelonickSJ CollinsInduction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acidProc Natl Acad Sci USA7729362940198010.1073/pnas.77.5.2936
13.	C MiyauraE AbeT Kuribayashi1,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cellsBiochem Biophys Res Commun102937943198110.1016/0006-291X(81)91628-46946774
14.	ED BallPM GuyreL ShenInterferon induces monocytoid differentiation in the HL-60 cell lineJ Clin Invest7310721077198410.1172/JCI1112926231309
15.	G RoveraD SantoliC DamskyHuman promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diesterProc Natl Acad Sci USA7627792783197910.1073/pnas.76.6.2779288066
16.	SA FischkoffA PollakGJ GleichEosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60J Exp Med160179196198410.1084/jem.160.1.1796588134
17.	B ChorváthJ SedlákN FuchsbergerInterferon α-induced modulation of leukocyte cell surface antigens: immunocytofluorometric study with human leukaemia/lymphoma cell linesActa Virol357181991
18.	JJ YunisH BandF BonnevilleEJ YunisDifferential expression of MHC class II antigens in myelomonocytic leukemia cell linesBlood7393193719892465791
19.	F Santiago-SchwarzDL CoppockAA HindenburgJ KernIdentification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemiaBlood843054306219947949177
20.	GK KoskiGN SchwartzDE WengCalcium ionophore-treated myeloid cells acquire many dendritic cell characteristics independent of prior differentiation state, transformation status, or sensitivity to biologic agentsBlood94135913711999
21.	Q LiH OzerI LindnerProtein kinase C blockade inhibits differentiation of myeloid blasts into dendritic cells by calcium ionophore A23187Int J Hematol81131137200510.1532/IJH97.NA0405
22.	TN NguyenBH ChoiHK KangOptimization and limitation of calcium ionophore to generate DCs from acute myeloid leukemic cellsCancer Res Treat39175180200710.4143/crt.2007.39.4.17519746185
23.	M LanotteTV MartinS NajmanNB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)Blood771080108619911995093
24.	HY ParkJY ParkJW KimDifferential expression of dendritic cell markers by all-trans retinoic acid on human acute promyelocytic leukemic cell lineInt Immunopharmacol415871601200410.1016/j.intimp.2004.07.01015454112
25.	WT DaltonMJ AhearnKB McCredieHMO cell line was derived from a patient with FAB-M2 and not FAB-M3Blood7124224719883422031
26.	I Pitha-RoweWJ PettyS KitareewanE DmitrovskyRetinoid target genes in acute promyelocytic leukemiaLeukemia1717231730200310.1038/sj.leu.240306512970771
27.	LJ ZhouTF TedderHuman blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamilyJ Immunol1543821383519957706722
28.	S YoshimuraJ BondesonBM FoxwellEffective antigen presentation by dendritic cells is NF-κB dependent: coordinate regulation of MHC, costimulatory molecules and cytokinesInt Immunol136756832001
29.	S BerchtoldP Mühl-ZürbesE MaczekCloning and characterization of the promoter region of the human CD83 geneImmunobiology205231246200210.1078/0171-2985-0012812182451
30.	JO JinHY ParkJW KimPhosphatidic acid induces the differentiation of human acute promyelocytic leukemic cells into dendritic cell-likeJ Cell Biochem100191203200710.1002/jcb.2105416924673
31.	K LarssonM LindstedtCA BorrebaeckFunctional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cellsImmunology117156166200610.1111/j.1365-2567.2005.02274.x16423051
32.	SJ SantegoetsMW SchreursAJ MastersonIn vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell lineCancer Immunol Immunother5514801490200610.1007/s00262-006-0142-x16468034
33.	ZB HuW MaM ZaborskiEstablishment and characterization of two novel cytokine responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3Leukemia101025104019968667638
34.	AJ MastersonCC SombroekTD De GruijlMUTZ-3, a human cell line model for the cytokine induced differentiation of dendritic cells from CD34+ precursorsBlood1007017032002
35.	SJ SantegoetsAJ MastersonPC van der SluisA CD34(+) human cell line model of myeloid dendritic cell differentiation: evidence for a CD14(+)CD11b(+) Langerhans cell precursorJ Leukoc Biol80133713442006
36.	KD KimSC ChoiYW NohImpaired responses of leukemic dendritic cells derived from a human myeloid cell line to LPS stimulationExp Mol Med387284200610.1038/emm.2006.916520555
37.	SJ SantegoetsAJ van den EertweghAA van de LoosdrechtHuman dendritic cell line models for DC differentiation and clinical DC vaccination studiesJ Leukoc Biol8413641373200810.1189/jlb.020809218664532
38.	I NelissenI SelderslaghsRV HeuvelMUTZ-3-derived dendritic cells as an in vitro alternative model to CD34+ progenitor-derived dendritic cells for testing of chemical sensitizersToxicol In Vitro2314771481200919732821
39.	JF ArrighiM RebsamenF RoussetA critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-α and contact sensitizersJ Immunol16638373845200111238627
40.	BC HuletteCA RyanGF GerberickElucidating changes in surface marker expression of dendritic cells following chemical allergen treatmentToxicol Appl Pharmacol182226233200210.1006/taap.2002.944712183102
41.	P AzamJL PeifferD ChamoussetThe cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizersToxicol Appl Pharmacol2121423200610.1016/j.taap.2005.06.01816039684
42.	S TsuchiyaM YamabeY YamaguchiEstablishment and characterization of a human acute monocytic leukemia cell line (THP-1)Int J Cancer26171176198010.1002/ijc.29102602086970727
43.	H SchwendeE FitzkeP AmbsP DieterDifferences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3J Leukoc Biol5955556119968613704
44.	MG NeteaEC LewisT AzamInterleukin-32 induces the differentiation of monocytes into macrophage-like cellsProc Natl Acad Sci USA10535153520200810.1073/pnas.071238110518296636
45.	C BergesC NaujokatS TinappA cell line model for the differentiation of human dendritic cellsBiochem Biophys Res Commun333896907200510.1016/j.bbrc.2005.05.17115963458
46.	M RosenzwajgB CanqueJC GluckmanHuman dendritic cell differentiation pathway from CD34+ hematopoietic precursor cellsBlood875355441996
47.	LJ ZhouTF TedderCD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cellsProc Natl Acad Sci USA93258825921996
48.	F SallustoM CellaC DanieliA LanzavecchiaDendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial productsJ Exp Med182389400199510.1084/jem.182.2.389
49.	P MontiA MercalliBE LeoneRapamycin impairs antigen uptake of human dendritic cellsTransplantation75137145200310.1097/00007890-200301150-0002512544886
50.	F SallustoA LanzavecchiaEfficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor αJ Exp Med1791109111819948145033
51.	G FerlazzoA WesaWZ WeiA GalyDendritic cells generated either from CD34+ progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8+ T cellsJ Immunol163359736041999
52.	LA LyakhGK KoskiW TelfordBacterial lipopolysaccharide, TNF-α, and calcium ionophore under serum-free conditions promote rapid dendritic cell-like differentiation in CD14+ monocytes through distinct pathways that activate NK-jBJ Immunol165364736552000
53.	MB FariesI BedrosianS XuCalcium signaling inhibits interleukin-12 production and activates CD83+ dendritic cells that induce Th2 cell developmentBlood9824892497200111588047
54.	CB LozzioBB LozzioHuman chronic myelogenous leukemia cell line with positive Philadelphia chromosomeBlood453213341975163658
55.	PJ FialkowClonal origin of human tumorsAnnu Rev Med30135143197910.1146/annurev.me.30.020179.001031
56.	AR GreenS RockmanE DeLucaCG BegleyInduced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restrictionExp Hematol215255311993
57.	GL Bianchi ScarráM RomaniDA CovielloTerminal erythroid differentiation in the K-562 cell line by 1-beta-D-arabinofuranosylcytosine: accompaniment by c-myc messenger RNA decreaseCancer Res466327633219863536078
58.	GP ToniniD RadziochA GronbergErythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562Cancer Res474544454719873476195
59.	Y HonmaJ Okabe-KadoM HozumiInduction of erythroid differentiation of K562 human leukemic cells by herbimycin A. an inhibitor of tyrosine kinase activityCancer Res4933133419892910452
60.	JA SutherlandAR TurnerP MannoniDifferentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineagesJ Biol Response Mod525026219862425057
61.	I LindnerMA Kharfan-DabajaE AyalaInduced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABLJ Immunol17117801791200310.4049/jimmunol.171.4.178012902478
62.	M MontanariC GemelliE TenediniCorrelation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14− and CD14+ human normal myeloid precursorsCell Death Differ1215881600200515947790
63.	B PlatzerA JörglS TaschnerRelB regulates human dendritic cell subset development by promoting monocyte intermediatesBlood10436553663200410.1182/blood-2004-02-041215315978